Adverse Effects of Particular Interest In the FOURIER trial, as discussed below, there was a marginal trend of some adverse effects of particular interest to occur more frequently in the evolocumab group than placebo including muscle-related events, incidence of diabetes, and neurocognitive events as discussed below [ 4 ].
1
—
—